9,030 followers
A recent publication on a forgotten class of #antidepressants #MAOI #Psychotropics Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? | SpringerLink https://t.co/7gzUqtTZws
Antidepressants
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 133 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
-
Altmetric BadgeChapter 152 Current Role of Herbal and Natural Preparations
-
Altmetric BadgeChapter 153 Clinical Implications of the STAR*D Trial
-
Altmetric BadgeChapter 155 The Use of Antidepressants in Bipolar Depression
-
Altmetric BadgeChapter 156 Impact, Diagnosis, Phenomenology, and Biology
-
Altmetric BadgeChapter 157 Neurostimulation Therapies
-
Altmetric BadgeChapter 161 Therapeutic Drug Monitoring of Antidepressants
-
Altmetric BadgeChapter 162 Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders
-
Altmetric BadgeChapter 163 Treatment of Depression in Women
-
Altmetric BadgeChapter 164 Serotonin and Norepinephrine Reuptake Inhibitors
-
Altmetric BadgeChapter 165 NMDA Antagonists for Treatment-Resistant Depression
-
Altmetric BadgeChapter 166 Role of Inflammation in Depression and Treatment Implications
-
Altmetric BadgeChapter 167 Other Antidepressants
-
Altmetric BadgeChapter 169 Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development
-
Altmetric BadgeChapter 170 Management of Late-Life Depression
-
Altmetric BadgeChapter 171 Pharmacogenomics and Biomarkers of Depression
-
Altmetric BadgeChapter 172 Selective Serotonin Reuptake Inhibitors
Attention for Chapter 133:
Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?